Tuesday, March 26, 2019 10:28:47 PM
Annual Meeting Keynote
ASENT is pleased to announce that Dr. Robert Temple, MD, CDER’s Deputy Center Director for Clinical Science and Acting Deputy Director of the Office of Drug Evaluation, will deliver a keynote address at the ASENT 2019 Annual Meeting. Dr. Temple will share his knowledge on trial design, new design parameters, outcomes and new approaches using genetics and molecular biology to enrich the clinical studies.
Dr. Temple’s keynote will take place on Tuesday, March 26, 2019 at 8:00 am, at the Bethesda North Marriott in Rockville, MD. We are pleased to welcome Dr. Temple and hope you will have the opportunity to hear this important presentation.
https://www.asent.org/?
Poster:
Page 9
Day 2:Wednesday, March 27 3:30-5pm
The ASENT Pipeline Sessions are brief podium presentations. These presentations are derived from the abstract submissions and vetted by our abstract review committee to ensure the highest caliber and most novel research.
Page 10
3:48 - 4:03 PM
Salons A-B
Longitudinal 148-Week Extension Study Of Anavex®2-73 For The Treatment Of Alzheimer’s
Disease Demonstrates Maintained Activities Of Daily Living Score (ADCS-ADL) And Reduced
Cognitive Decline (MMSE) For Patient Cohort On Higher Drug Concentration And Confirms
Role Of Precision Medicine Patient Selection Biomarkers
Walter E. Kaufmann, MD, Anavex Life Sciences
Page 16 - Posters
5 LONGITUDINAL 148-WEEK EXTENSION STUDY OF ANAVEX®2-73 FOR THE TREATMENT OF
ALZHEIMER’S DISEASE DEMONSTRATES MAINTAINED ACTIVITIES OF DAILY LIVING SCORE (ADCSADL) AND REDUCED COGNITIVE DECLINE (MMSE) FOR PATIENT COHORT ON HIGHER DRUG
CONCENTRATION AND CONFIRMS ROLE OF PRECISION MEDICINE PATIENT SELECTION
BIOMARKERS
Harald Hampel, Mohammad Afshar, Frédéric Parmentier, Coralie Williams, Adrien Etcheto, Federico Goodsaid, Christopher U Missling
https://cdn.ymaws.com/www.asent.org/resource/resmgr/docs/19_annual_meeting/onsite_program_19_v2a.pdf
Recent TAOX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:02:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:01:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:01:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 09:21:40 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/02/2026 09:32:45 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/02/2026 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 09:23:07 PM
- TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation • PR Newswire (US) • 11/18/2025 02:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/12/2025 09:10:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/07/2025 09:41:16 PM
- TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds • PR Newswire (US) • 11/04/2025 02:15:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 10/24/2025 08:12:47 PM
- TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency • PR Newswire (US) • 10/20/2025 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2025 09:13:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 10:12:21 AM
- TAO Synergies Announces $11 Million Private Placement • PR Newswire (US) • 10/13/2025 09:09:00 PM
- TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO) • PR Newswire (US) • 09/22/2025 01:15:00 PM
- TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event • PR Newswire (US) • 09/08/2025 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 09:00:44 PM
- TAO Synergies Welcomes Top Bittensor (TAO) Leader as Advisor for AI-Focused Crypto Treasury Strategy • PR Newswire (US) • 08/26/2025 01:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/14/2025 08:51:57 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/14/2025 08:50:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 08:19:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 09:17:38 PM

